Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10538513
APP PUB NO 20190315724A1
SERIAL NO

16456179

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THERAVANCE BIOPHARMA R&D IP, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dabros, Marta Foster City, US 20 138
Fenster, Erik San Bruno, US 31 136
Lam, Tom M San Francisco, US 8 14
McKinnell, Robert Murray Millbrae, US 78 592
Nzerem, Jerry South San Francisco, US 15 87
Rapta, Miroslav San Carlos, US 66 436
Thalladi, Venkat R Foster City, US 50 194

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 21, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 21, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00